B cells in Sjögren's syndrome: from pathophysiology to therapeutic target
- PMID: 30770916
- DOI: 10.1093/rheumatology/key332
B cells in Sjögren's syndrome: from pathophysiology to therapeutic target
Abstract
Biological abnormalities associated with B lymphocytes are a hallmark of patients with primary Sjögren's syndrome. Those patients present abnormal distribution of B lymphocytes in peripheral blood and B cells in exocrine glands. B cells produce auto-antibodies, cytokines and present antigens but can also suppressive functions. In this review, we will summarize current knowledge on B cells in primary Sjögren's syndrome patients, demonstrate their critical role in the immunopathology of the disease and describe the past and current trials targeting B cells.
Keywords: B cells; BAFF; autoreactivity; cytokines; ectopic germinal centers; epigenetics; immunotherapy; lymphoma; primary Sjögren’s syndrome; regulation.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous